Sign In
Buy SAGE
$8.68
+0 (+0%)
At Close: Oct 30, 2025
Why Is Sage Therapeutics, Inc. (SAGE) Down 22% Since Last Earnings Report?
12:35pm, Friday, 15'th Mar 2024
Sage Therapeutics, Inc. (SAGE) reported earnings 30 days ago. What's next for the stock?
Sage Therapeutics to Present at Upcoming March Investor Conferences
06:30am, Wednesday, 28'th Feb 2024
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will
Sage Therapeutics (SAGE) Q4 Earnings & Revenues Beat Estimates
02:41pm, Thursday, 15'th Feb 2024
Sage Therapeutics' (SAGE) earnings and revenues surpass estimates in the fourth quarter of 2023. Focus on newly launched PPD drug, Zurzuvae.
Sage Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 14, 2024
06:30am, Wednesday, 31'st Jan 2024
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced that it will host a l
Sage Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024
06:30am, Tuesday, 02'nd Jan 2024
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will
5 Biotech stocks tapping into unmet mental health treatment needs
09:01am, Wednesday, 20'th Dec 2023
Anyone who has dealt with a mental illness or has a loved one who struggles with a mental illness knows how devastating these diseases are. However, a growing number of biotechnology companies are giv
Sage Therapeutics (SAGE) Q3 Earnings Lag Estimates, Down 5%
02:17pm, Wednesday, 08'th Nov 2023
Sage Therapeutics (SAGE) reports dismal third-quarter results. It intends to price the recently approved oral postpartum depression pill Zurzuvae at $15,900 for an entire 14-day treatment course.
Why Sage Therapeutics Stock Sank Today
06:02pm, Tuesday, 07'th Nov 2023
Third-quarter figures were not inspiring to investors. The biotech missed rather badly on both the top and bottom lines.
SAGE Therapeutics, Inc. (SAGE) Q3 2023 Earnings Call Transcript
03:27pm, Tuesday, 07'th Nov 2023
SAGE Therapeutics, Inc. (NASDAQ:SAGE ) Q3 2023 Earnings Conference Call November 7, 2022 8:00 AM ET Company Participants Ashley Kaplowitz - Director, IR Barry Greene - President, CEO & Director Christ
Sage Therapeutics, Inc. (SAGE) Reports Q3 Loss, Misses Revenue Estimates
09:01am, Tuesday, 07'th Nov 2023
Sage Therapeutics, Inc. (SAGE) came out with a quarterly loss of $2.81 per share versus the Zacks Consensus Estimate of a loss of $2.64. This compares to loss of $2.31 per share a year ago.
Biotech/Drug Stocks Q3 Earnings Due Nov 7: GILD, PRGO, VTRS & More
09:47am, Monday, 06'th Nov 2023
Let us take a look at what's in store for biotech/drug stocks GILD, PRGO, VTRS, SAGE and IOVA, which are scheduled to report on Nov 7.
Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023
06:30am, Tuesday, 24'th Oct 2023
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a l
Sage Therapeutics: Several Neuropsychiatric Disorder Data Readouts In 2024
06:52pm, Wednesday, 18'th Oct 2023
Sage Therapeutics, Inc. received FDA approval along with Biogen for its drug ZURZUVAE for the treatment of postpartum depression, with a planned launch in Q4 2023. The company has several ongoing stud
Sage Therapeutics jump 5% on Huntington's drug call by FDA
07:41am, Wednesday, 18'th Oct 2023
Shares of Sage Therapeutics Inc jumped 5% in premarket trading following the announcement that the US Food and Drug Administration (FDA) has granted orphan-drug status to SAGE-718, a treatment for H
3 Healthcare Stocks to Sell in September Before They Crash & Burn
02:27pm, Wednesday, 06'th Sep 2023
The healthcare industry comprises multiple sectors, including biotechnology, pharmaceuticals, and healthcare equipment, each offering a unique and potentially risky opportunity. News regarding FDA app
